May 24, 2023—Hologic announced the FDA has granted 510(k) clearance for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay. The post FDA clears Panther Fusion SARS-CoV-2/Flu A/B/RSV assay    first appeared on CAP TODAY. The post FDA clears Panther Fusion SARS-CoV-2/Flu A/B/RSV assay    appeared first on CAP TODAY ..read more

May 22, 2023—X-Lab announced that TriCore Reference Laboratories will go live with its product Labgnostic to transition TriCore's paper-based orders and results workflows to fully electronic workflows. The post TriCore goes live with X-Lab’s Labgnostic first appeared on CAP TODAY. The post TriCore goes live with X-Lab’s Labgnostic appeared first on CAP TODAY ..read more

May 18, 2023—Siemens Healthineers launched two solutions for high-volume hematology testing, the Atellica Hema 570 analyzer and Atellica Hema 580 analyzer. The post Siemens launches Atellica Hema analyzers first appeared on CAP TODAY. The post Siemens launches Atellica Hema analyzers appeared first on CAP TODAY ..read more

May 2023—Behold the common coin. Note its two sides, its easy flippability. Here is Joseph Pizzolato, MD, with the first coin toss. Given the expanded use of biomarkers with a variety of tumors, and constantly evolving assays, how hard is it for medical oncologists to navigate testing? “It’s not difficult at all now,” says a cheerful Dr. Pizzolato, medical director of the comprehensive therapeutic unit of Sylvester Comprehensive Cancer Center, University of Miami Health System, as well as medical director of the Aventura satellite at Sylvester. With third-party companies integrating test order ..read more

May 2023—For fluid biomarkers in the diagnosis of Alzheimer’s disease, the pace of research and related industry and regulatory developments in the past year has been brisk. The post Alzheimer’s biomarkers: CSF reports, plasma prospects first appeared on CAP TODAY. The post Alzheimer’s biomarkers: CSF reports, plasma prospects appeared first on CAP TODAY ..read more

May 2023—Of the five methods used to measure HbA1c—immunoassay, boronate affinity, enzymatic, capillary electrophoresis, and ion-exchange HPLC—only the latter two can alert the laboratory and physician to the presence of a suspected hemoglobin variant. Even so, there are reasons to be cautious. The post ‘Hundreds of variants’—Staying alert to HbA1c method interference first appeared on CAP TODAY. The post ‘Hundreds of variants’—Staying alert to HbA1c method interference appeared first on CAP TODAY ..read more

May 2023—Achieving standardization and setting up processes around the use of next-generation sequencing panels for the care of patients with cancer is a long road requiring a lot of expertise. The post In-house or send-out? Lab approaches to gene panels first appeared on CAP TODAY. The post In-house or send-out? Lab approaches to gene panels appeared first on CAP TODAY ..read more

May 2023—When hiring is difficult, how to improve retention becomes what it’s all about. Linking sign-on bonuses with performance metrics rather than time in the job is one way to try to retain employees in an industry in which demand for staff far outweighs the supply. The post Supported? Satisfied? Keeping staff from moving on first appeared on CAP TODAY. The post Supported? Satisfied? Keeping staff from moving on appeared first on CAP TODAY ..read more

May 2023—How to distinguish appendiceal diverticular disease and appendiceal polyps from mucinous neoplasms was just part of a CAP22 course on appendiceal lesions, led by Maryam Pezhouh, MD, MSc, of the University of California, San Diego, and Jacqueline Birkness-Gartman, MD, of Johns Hopkins University School of Medicine. The post Appendiceal lesion cases, clues, and cautions first appeared on CAP TODAY. The post Appendiceal lesion cases, clues, and cautions appeared first on CAP TODAY ..read more

May 2023—Bringing next-generation sequencing in-house was at the center of a March 27 roundtable led by CAP TODAY publisher Bob McGonnagle, with costs, reimbursement, equity, and the electronic health record part of the conversation. Jeremy Segal, MD, PhD, of the University of Chicago, explains why the Genomics Organization for Academic Laboratories was formed. “By lowering barriers and encouraging cooperation,” he said, “we’ve seen our labs increase the pace of development and the quality of the assays they’re bringing on.” The post The outlook for in-house next-generation sequencing first ap ..read more